baber/WOPTO huggingface dataset:
Patent AU-2012216966-B2 (AU)
Title: Milk-based product and a method for its preparation
Inventor: TIKANMAKI REETTA
IPC: A23C21/00
Filed: 2012-02-16
Granted: 2016-04-21
Abstract: The invention relates to a whey protein product having a ratio of whey protein to casein in the range from about 25:75 to about less than 50:50, a total protein content of at least 20% on dry matter basis, and a protein content of about 2.5 to about 8% by weight, based on the weight of the product. The product has a favourable amino acid composition and is especially suitable for athletes. The invention also relates to a method for producing a whey protein product, using microfiltration and ultrafiltration. The whey protein product is composed of the ultrafiltration re- tentate and a casein-containing material at a ratio of whey protein to casein of about 20:80 to about less than 50:50 and a total protein content of at least about 20% on dry matter basis.
Patent AU-2012244247-B2 (AU)
Title: Wheel end assembly high-temperature warning system
Inventor: SONZALA FRANK JOSEPH
IPC: B61K9/04
Filed: 2012-10-30
Granted: 2014-03-06
Abstract: A high-temperature warning system mounted on a vehicle having an axle and a wheel-end assembly rotatable thereon, the high-temperature warning system including: an air pressure supply in the axle and connected to a pressure source on the vehicle; a normally closed valve connected to said air pressure supply, the valve capable of opening upon actuation to release air from the air pressure supply to atmosphere, the valve mounted to the axle or at a location other than on the rotatable wheel-end assembly; a thermal electric switch connected to said valve, the thermal electric switch capable of actuating the valve upon a predetermined temperature, the thermal electric switch mounted adjacent said wheel end assembly so as to allow detection of heat from the wheel-end assembly; and a warning system connected to the pressure supply, the warning system capable of actuating upon opening of the valve.
Patent AU-2012339870-B2 (AU)
Title: Substituted cyclopropyl compounds useful as GPR119 agonists
Inventor: EDMONDSON SCOTT
IPC: C07D401/00
Filed: 2012-11-09
Granted: 2017-06-29
Abstract: Substituted cyclopropyl compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included
Patent AU-2012340670-B2 (AU)
Title: Cysteamine and/or cystamine for treating ischemic injury
Inventor: DOHIL RANJAN
IPC: A61K31/145
Filed: 2012-11-21
Granted: 2016-12-22
Abstract: Provided herein are methods and compositions for treating ischemia or a disease or disorder that causes ischemia comprising contacting a subject with cysteamine, a cysteamine derivative, cystamine or a cystamine derivative. The disclosure also provides methods of modulating adiponectin levels in a subject comprising contact a subject with cysteamine, a cysteamine derivative, cystamine or a cystamine derivative.
Patent AU-2013200388-B2 (AU)
Title: Compositions and methods for the treatment of infections and tumors
Inventor: SHARPE ARLENE
IPC: A61K31/20
Filed: 2013-01-23
Granted: 2014-10-23
Abstract: PD-I antagonists are disclosed that can be used to reduce the expression or activity of PD-I in a subject. An immune response specific to an infectious agent or to tumor 5 cells can be enhanced using these PD- 1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-I antagonists. In addition, subjects with tumors can be treated using the PD-I antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that 10 recognize an antigen of interest and by administering a therapeutically effective amount of a PD-I antagonist.
Patent AU-2013200759-B2 (AU)
Title: CO2 absorption from gas mixtures using an aqueous solution of 4-amino- 2,2,6,6-tetramethylpiperidine
Inventor: SEILER MATTHIAS
IPC: B01D53/62
Filed: 2013-02-13
Granted: 2013-07-18
Abstract: CO 2 ABSORPTION FROM GAS MIXTURES USING AN AQUEOUS SOLUTION OF 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE CO 2 is absorbed from a gas mixture by bringing the gas mixture into contact with an absorbent 5 that comprises water and at least one amine of the formula (I), wherein R1 and R2, independently of each other, are hydrogen or an alkyl group. According to the invention, absorption media comprise sulfolane or an ionic liquid in addition to water and an amine of the formula (I). A device according to the invention for removing CO 2 from a gas mixture comprises an absorption unit, a desorption unit, and an absorption medium according to the invention that is conducted in [0 the circuit. (I)
Patent AU-2013201237-B2 (AU)
Title: Selective placement of conformance treatments in multi-zone well completions
Inventor: KALMAN MARK D
IPC: E21B33/13
Filed: 2013-03-04
Granted: 2013-06-06
Abstract: Selective placement of conformance treatments in multi-zone well completions. A method includes injecting a relative permeability modifier into a zone and optimizing a ratio of desired fluid to undesired fluid produced from the zone, including adjusting at least one flow control device between fully open and fully closed configurations. Another method includes injecting a relative permeability modifier into multiple zones, one at a time, via respective flow control devices, and then producing fluid from each of the zones. Another method includes identifying which of the zones to treat by, for each of the zones: a) closing flow control devices corresponding to the other zones, and b) evaluating fluid produced from the zone; and injecting a conformance treatment into the zones identified as the zones to treat. C* C%,4 /t
Patent AU-2013202059-B2 (AU)
Title: Reversible peristaltic pump and other structures for reflux in eye surgery
Inventor: KING DAVID A
IPC: A61M1/00
Filed: 2013-03-27
Granted: 2015-01-22
Abstract: Document 12-27/03/2013 Devices, systems, and methods for treatment of an eye alter aspiration flow from the eye in 5 response to an occlusion of the aspiration conduit pathway. Where aspiration is drawn from the eye (E) using a volumetric pump (54), the pump (54) can be reversed so as to induce fluid reflux from the aspiration conduit pathway into the eye (E) to help clear the occlusion. The pump may vary the reverse flow in response to sensed aspiration pressure or the like, and the reverse flow may be halted before the pressure within the aspiration 10 conduit pathway adjacent the eye significantly exceeds the irrigation fluid pressure and/or the pressure within the eye. Reflux may alternatively be generated by modulating a vent valve (55) disposed between an irrigation conduit pathway and the aspiration conduit pathway.
Patent AU-2013202329-B2 (AU)
Title: Non-protein stabilized clostridial toxin pharmaceutical compositions
Inventor: HUNT TERRENCE J
IPC: A61K47/10
Filed: 2013-04-03
Granted: 2016-04-14
Abstract: NON-PROTEIN STABILIZED CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS A Clostridial toxin pharmaceutical composition comprising a Clostridial toxin, such as a botulinum toxin, wherein the Clostridial toxin present in the pharmaceutical composition is stabilized by a non-protein excipient such as a polyvinylpyrrolidone, a disaccharides, a trisaccharide, a polysaccharide, an alcohol, a metal, an amino acid, a surfactant and/or a polyethylene glycol.
Patent AU-2013224702-B2 (AU)
Title: Light
Inventor: ROTGERI GERHARD
IPC: G08B5/36
Filed: 2013-09-05
Granted: 2015-07-09
Abstract: Abstract A light (1), in particular a safety light or emergency sign light, comprises a transparent light-guiding and distributing plate (2), a number of LEDs (4) assigned to at least one light entry edge (3) of the light-guiding and distributing plate (2), and at least one pictogram (6) assigned to a lateral light-emitting surface (5) of the light-guiding and distributing plate (2). In order to realize a light of a flat design and with a uniform illumination in particular of the pictogram along with a simple construction and in a cost-efficient manner an adhesive layer (7) structured for light distribution is arranged between the pictogram (6) and the light-emitting surface (5). Figure 1 6,112 8 /9,13 7,10 6,11
Patent AU-2013230886-B2 (AU)
Title: Renal neuromodulation methods and systems for treatment of hyperaldosteronism
Inventor: BRENNAN GABRIEL
IPC: A61N1/36
Filed: 2013-03-07
Granted: 2015-10-01
Abstract: Methods for treating hyperaldosteronism with therapeutic renal neuromodulation and associated systems and methods are disclosed herein. One aspect of the present technology, for example, is directed to methods that at least partially inhibit sympathetic neural activity in renal nerves proximate a renal blood vessel of a human patient. One or more measurable physiological parameters corresponding to hyperaldosteronism of the patient can thereby be improved. Moreover, central sympathetic drive in the patient can be reduced in a manner that treats the patient for hyperaldosteronism. Renal sympathetic nerve activity can be modulated along the afferent and/or efferent pathway. The modulation can be achieved, for example, using an intravascularly positioned catheter carrying a neuromodulation assembly, e.g., a neuromodulation assembly configured to use electrically-induced, thermally-induced, and/or chemically-induced approaches to modulate the renal nerve.
Patent AU-2013251363-B2 (AU)
Title: Non-invasive automated electrical control systems and methods for monitoring animal conditions
Inventor: BESIO WALTER G
IPC: G01N27/00
Filed: 2013-04-26
Granted: 2018-11-15
Abstract: The present invention employed a method to control electrical activity in a target area of an animal' s body by administering transcranial focal stimulation to the target area to adjust activity to normal levels. An advanced automated control system would first detect the abnormal electrical activity using tripolar concentric ring electrodes and then provides transcranial focal electrical stimulation to the target area using noninvasive tripolar concentric ring electrode system in a closed-loop continuous feedback. The automated control system wou ld be adaptable to include the use of therapeutic drugs, either non-continuously or continuously, as a more comprehensive treatment of the abnormal electric activity.
Patent AU-2013266649-B2 (AU)
Title: Fully polymerized UV blocking silicone hydrogel lens
Inventor: NUNEZ IVAN M
IPC: G02B1/04
Filed: 2013-05-20
Granted: 2016-04-14
Abstract: A substantially fully copolymerized UV blocking hydrogel lens demonstrating sufficient blocking of UV light to meet at least FDA Class II specifications for UV blocking formed from a reaction mixture comprising at least NVP and one other comonomer and a free-radical polymerizable, substituted or unsubstituted, Bis
Patent AU-2013298403-B2 (AU)
Title: Control of arthropod infestation
Inventor: JESSOP NICHOLAS HUGH HYLTON
IPC: A01N57/16
Filed: 2013-07-29
Granted: 2016-08-04
Abstract: Use of particles in controlling a population of arthropod pests, wherein the particles comprise i) a hydrophobic exterior that adheres to the cuticle of at least one species of an arthropod pest; and ii) at least one pesticide associated with the said particles, wherein the pesticide is present at a weight of no more than 2% of the weight of the particles, populations of particles, methods of producing populations of particles and methods of application of such populations.
Patent AU-2013305941-B2 (AU)
Title: Implantable electrical stimulation systems with shielded control module and methods for making and using
Inventor: GUPTA GAURAV
IPC: A61N1/375
Filed: 2013-08-20
Granted: 2016-05-19
Abstract: An implantable control module for an electrical stimulation system includes a header coupled a sealed body. The header includes at least one connector assembly. The control module also includes a conductive shield disposed over at least a portion of the connector assembly or connector assemblies of the header. The conductive shield is provided to hinder generation of current in the header or in a portion of a lead received in the header in response to application of an external radiofrequency (RF) or magnetic field. A similar shield can also be used to shield a connector assembly disposed on the end of a lead extension or any other component of the electrical stimulation system.
Patent AU-2013331272-B2 (AU)
Title: Systems and methods for managing hydrocarbon material producing wellsites using clamp-on flow meters
Inventor: DRAGNEA GABRIEL
IPC: E21B47/10
Filed: 2013-10-16
Granted: 2016-12-22
Abstract: A method and system for managing one or more hydrocarbon producing well sites is provided. The well site includes a hydrocarbon material flow passing through a pipe. The system includes a clamp-on flow meter and a control station. The clamp-on flow meter is operable to produce output indicative of at least one characteristic of the hydrocarbon material flowing through the pipe at the well site. The control station is separately located from the well site. The control station includes at least one processor adapted to receive the output from the clamp-on flow meter. The processor is adapted to determine one or more characteristics of the hydrocarbon material flow at each well site using a flow compositional model.
Patent AU-2013408898-B2 (AU)
Title: Film compositions for oral use
Inventor: SZEWCZYK GREGORY
IPC: A61K8/02
Filed: 2013-12-23
Granted: 2017-02-23
Abstract: Described herein are oral compositions comprising a film, wherein the film comprises a dye entrapped in a silica sol-gel.
Patent AU-2014200370-B2 (AU)
Title: Catheter having flat beam deflection tip with fiber puller members
Inventor: JIMENEZ JOSE
IPC: A61M25/01
Filed: 2014-01-22
Granted: 2017-11-02
Abstract: A catheter has a metal deflection beam with rectangular cross-section and one or two fiber puller members for predictable on-plane bi-directional deflection. Each fiber puller member is anchored at its distal end to a respective surface of the beam by a metal ferrule that is crimped onto the distal end. The ferrule is shaped to provide a flat outer underside that can lie flat against a beam surface and a thin planar distal section that is welded to the beam. With a distal end of the beam sandwiched between the thin planar distal section of two ferrules, the ferrules and the beam can be welded together by a single laser pulse.
Patent AU-2014202630-B2 (AU)
Title: Method, base station, terminal and communication system for selecting a component carrier
Inventor: WEI YUXIN
IPC: H04W48/00
Filed: 2014-05-14
Granted: 2016-02-25
Abstract: METHOD, BASE STATION, TERMINAL AND COMMUNICATION SYSTEM FOR SELECTING A COMPONENT CARRIER A method, base station, terminal and communication system for selecting a component carrier are provided in the present invention. The method includes the following steps: determining the coverage range of each available carrier which can be used by the terminal; determining whether the distribution of the coverage ranges of all available carriers accords with a preset distribution mode; in the case of according with the presetting distribution mode, at least according to a rule which is determined by the distribution mode, determining a component carrier to be used. With the embodiments provided in the invention, a component carrier used by the terminal can be reasonably chosen. 6714462_2
Patent AU-2014202863-B2 (AU)
Title: Update management method and apparatus
Inventor: SHIM JUNG-HYUN
IPC: G06F3/14
Filed: 2014-05-26
Granted: 2015-11-19
Abstract: Abstract An update management method and apparatus therefor are provided, the update management method including the operations of storing one or more pieces of update information related to at least one channel from a plurality of channels in a storage unit of a user terminal; and displaying the one or more pieces of update information in the related at least one channel.
Patent AU-2014203198-B2 (AU)
Title: Grain auger blow-out door
Inventor: HOUSSIAN TERRY DOUGLAS
IPC: B65G67/24
Filed: 2014-06-12
Granted: 2016-03-17
Abstract: A grain auger having a discharge chute with a primary opening is also provided with at least one secondary opening and a door movable between opened and closed positions relative to the secondary opening. The door is normally closed by spring bias, 5 but will open if the primary discharge opening becomes blocked, thereby releasing grain through the secondary opening, to prevent damage to the auger.
Patent AU-2014203834-B2 (AU)
Title: Control feedback loop for real-time variable needle peen forming
Inventor: LUNDQUIST LAUREN K
IPC: B24C1/10
Filed: 2014-07-14
Granted: 2017-09-28
Abstract: CONTROL FEEDBACK LOOP FOR REAL-TIME VARIABLE NEEDLE PEEN FORMING Method and apparatus are provided for processing and changing the physical characteristics of a metal workpiece into a final metal component. Predetermined processing parameters are established for achieving a final metal component. The metal workpiece (W) is positioned securely on a support (202) during the changing of the physical characteristics. Impacts are applied to a surface (206) of the workpiece multiple times for achieving the final metal component while controlling the impacting with the predetermined processing parameters. A sensor is provided for continuously sensing the currently existing physical conditions of the workpiece during impacting. The predetermined processing parameters are changed into adjusted processing parameters and the impacts are changed in reaction to the currently existing physical conditions of the workpiece from the sensing and processing of the workpiece until the final metal component has been achieved. CONTROLLER WITH PREDETERMINED PROCESSING PARAMETERS INSTALLED 252 IN POSITION FOR PROCESSING 26 IMPACT WORKPIECE UNDER 256 CONTROL OF PREDETERMINED PROCESSING PAR AMET ERS REAL TIME SENSING 258 OF CONDITIONS OF WORK PIECE ADJUST PROCESSING -260 PARAMETERS BASEDON SENSED CONDITIONS OF WORKPIECE CONTINUE IMPACT OF WORKPIECE WITH ADJUSTED PROCESSING 62 PARAMETERS UNTIL FINAL METAL COMPONENT IS ACHIEVED
Patent AU-2014218911-B2 (AU)
Title: Methods and compositions for nanostructure-based nucleic acid sequencing
Inventor: KOTSEROGLOU THEOFILOS
IPC: C12Q1/68
Filed: 2014-02-20
Granted: 2018-07-12
Abstract: Provided herein are nanostructure-based sequencing methods and systems.
Patent AU-2014219395-B2 (AU)
Title: Intravertebral tissue ablation device and method
Inventor: KRUEGER JOHN A
IPC: A61B18/14
Filed: 2014-02-04
Granted: 2017-06-29
Abstract: A tissue ablation device is provided for use in soft tissue and/or in bone. It is configured to include an inner probe with a first electrode and a second electrode and an outer needle through which the inner probe extends. After the inner probe is directed therewithin to a target, the outer needle can be withdrawn to expose space between the first and second electrodes to form an RF or other energy field for tissue ablation therebetween upon actuation of an energy source. Such embodiments may include methods for tissue ablation and placement of stabilizing materials.
Patent AU-2014256364-B2 (AU)
Title: Human domain antibodies against components of the human insulin-like growth factor (IGF) system
Inventor: DIMITROV DIMITER S
IPC: C07K16/22
Filed: 2014-10-30
Granted: 2016-07-07
Abstract: The invention provides antibodies or antibody fragments that bind to insulin-like growth factor (IGF) 1 receptor (IGF-1R) or IGF-2, as well as method of using the antibodies for inhibiting the IGF-mediated signaling pathway, inhibiting IGF-1R signaling, and treating cancer. The invention also provides a method of detecting the presence of IGF-1R or IGF-2 in a sample using the inventive antibodies and antibody fragments. 5902956_1 (GHMatters) P89761.AU.1 LEOWNR
Patent AU-2014262297-B2 (AU)
Title: Lenses, devices, methods and systems for refractive error
Inventor: BAKARAJU RAVI CHANDRA
IPC: G02B3/00
Filed: 2014-11-17
Granted: 2017-04-06
Abstract: Abstract The present disclosure is directed to lenses, devices, methods and/or systems for addressing refractive error. Certain embodiments are directed to changing or controlling the wavefront of the light entering a human eye. The lenses, devices, methods and/or systems can be used for correcting, addressing, mitigating or treating refractive errors and provide excellent vision at distances encompassing far to near without significant ghosting. The refractive error may for example arise from myopia, hyperopia, or presbyopia with or without astigmatism. Certain disclosed embodiments of lenses, devices and/or methods include embodiments that address foveal and/or peripheral vision. Exemplary of lenses in the fields of certain embodiments include contact lenses, comeal onlays, comeal inlays, and lenses for intraocular devices both anterior and posterior chamber, accommodating intraocular lenses, electro-active spectacle lenses and/or refractive surgery.
Patent AU-2014309243-B2 (AU)
Title: Personal respiratory protection device
Inventor: WALKER GARRY J
IPC: A41D13/11
Filed: 2014-08-13
Granted: 2017-07-27
Abstract: The present invention relates to a personal respiratory protection device, in particular, such a device comprising a respirator body having a periphery, a filter media, forming at least part of the respirator body, and a gasket, the gasket being located at the periphery and extending along at least a portion of its length.
Patent AU-2014342103-B2 (AU)
Title: Specific anti-CD38 antibodies for treating human cancers
Inventor: DESLANDES ANTOINE
IPC: A61K39/395
Filed: 2014-10-31
Granted: 2020-06-04
Abstract: The present disclosure concerns an antibody that specifically binds CD38 which is capable of killing a CD38+ cell by induction of apoptosis, antibody-dependent cell- mediated cytotoxicity (ADCC), and complement-dependent cytotoxicity. The disclosed antibody may be used as a medicament or in the making of a medicament, wherein the antibody is to be administered to a human subject in a safe therapeutic dose of about 20 mg/kg or below. In one embodiment, the medicament is for treating CD38+ multiple Myeloma in humans.
Patent AU-2015202141-B2 (AU)
Title: Route feature identification system and method
Inventor: NOFFSINGER JOSEPH FORREST
IPC: B61L25/02
Filed: 2015-04-27
Granted: 2018-01-18
Abstract: A system includes at least one application device, a control unit, and at least one processor. The at least one application device is conductively or inductively coupled with at least one of a first conductive track or a second conductive track. The control unit is configured to control supply of electric current from a power source to the at least one application device to electrically inject at least one examination signal into the conductive tracks. The at least one processor is configured to monitor the one or more electrical characteristics of at least one of the first or second conductive tracks, and to identify a construction feature of the route based on the one or more electrical characteristics, wherein the construction feature corresponds to a man-made aspect of the route. 602 Transmit examination signals 604 Monitor examination signals Compare collected signature to 606 Identify construction feature stored signature passed over Identify aspects of construction --- 610 612- Determine location of vehicle feature